Geode Capital Management
ZURA icon

Geode Capital Management’s Zura Bio ZURA Stock Holding History

Geode Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.14M Buy
527,691
+123,212
+30% +$744K ﹤0.01% 2951
2025
Q4 		$2.12M Sell
404,479
-825
-0.2% -$3.26K ﹤0.01% 3149
2025
Q3 		$1.76M Sell
405,304
-1,932
-0.5% -$3.47K ﹤0.01% 3222
2025
Q2 		$428K Sell
407,236
-585,780
-59% -$700K ﹤0.01% 3602
2025
Q1 		$1.28M Buy
993,016
+37,590
+4% +$59.3K ﹤0.01% 3218
2024
Q4 		$2.39M Buy
955,426
+42,801
+5% +$152K ﹤0.01% 3065
2024
Q3 		$3.71M Buy
912,625
+377,545
+71% +$1.41M ﹤0.01% 2907
2024
Q2 		$1.87M Buy
535,080
+47,955
+10% +$195K ﹤0.01% 3143
2024
Q1 		$1.25M Buy
487,125
+437
+0.1% +$1.55K ﹤0.01% 3279
2023
Q4 		$2.27M Buy
486,688
+223,768
+85% +$1.12M ﹤0.01% 3055
2023
Q3 		$1.74M Buy
262,920
+62,321
+31% +$417K ﹤0.01% 3116
2023
Q2 		$1.64M Buy
+200,599
New +$1.61M ﹤0.01% 3173

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Geode Capital Management's ZURA Position: Q1 2026 in Review

Geode Capital Management increased its Zura Bio (ZURA) stake by 30% in Q1 2026, buying an estimated $744K and bringing the position to 527,691 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

Geode Capital Management first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.71M in Q3 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Geode Capital Management held 527,691 shares of Zura Bio worth $3.14M as of Q1 2026.
  • Geode Capital Management bought 123,212 Zura Bio shares in Q1 2026, an estimated $744K.
  • Zura Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2951 holding.
  • Geode Capital Management first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • Geode Capital Management's Zura Bio position peaked at $3.71M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.